Insider Transactions Screener
Search for and identify insider purchases or sales of company shares. The screener offers additional information and analysis on the transactions and allows users to set up alerts and receive notifications when new transactions occur.
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
CNXN
|
Timothy J Mcgrath
President & CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 5,000 Added 1.86% |
-
|
Oct 29
2025 |
|
ACN
|
Julie Spellman Sweet
Chair and CEO |
SELL
Open market or private sale
|
Direct | 9,000 Reduced 38.27% |
$2,280,870
$253.43 p/Share
|
Oct 29
2025 |
|
UHS
|
Marc D Miller
President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct | 131,758 Reduced 29.74% |
$29,685,077
$225.3 p/Share
|
Oct 29
2025 |
|
UHS
|
Marc D Miller
President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct | 165,000 Added 27.14% |
$24,047,100
$145.74 p/Share
|
Oct 29
2025 |
|
GLW
|
Stefan Becker
SVP, Finance & Corp Controller |
SELL
Open market or private sale
|
Direct | 12,100 Reduced 70.56% |
$1,104,488
$91.28 p/Share
|
Oct 29
2025 |
|
EVCM
|
Eric Richard Remer
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 10,643 Reduced 0.35% |
$125,268
$11.77 p/Share
|
Oct 29
2025 |
|
GLW
|
Eric S Musser |
SELL
Open market or private sale
|
Direct | 100,000 Reduced 69.0% |
$9,017,000
$90.17 p/Share
|
Oct 29
2025 |
|
RE
|
William F Galtney Jr
Director |
BUY
Open market or private purchase
|
Indirect | 11,385 Added 0.0% |
$3,499,521
$307.38 p/Share
|
Oct 29
2025 |
|
APH
|
Lance E D'Amico
Sr. VP, Secretary & GenCounsel |
SELL
Open market or private sale
|
Direct | 120,000 Reduced 61.1% |
$16,801,200
$140.01 p/Share
|
Oct 29
2025 |
|
APH
|
Lance E D'Amico
Sr. VP, Secretary & GenCounsel |
BUY
Exercise of conversion of derivative security
|
Direct | 120,000 Added 37.93% |
$2,706,000
$22.55 p/Share
|
Oct 29
2025 |
|
RE
|
Allan Levine
Director |
BUY
Open market or private purchase
|
Direct | 3,100 Added 42.74% |
$948,848
$306.08 p/Share
|
Oct 29
2025 |
|
APH
|
William J Doherty
President, CS Division |
SELL
Open market or private sale
|
Direct | 80,000 Reduced 100.0% |
$11,283,200
$141.04 p/Share
|
Oct 29
2025 |
|
APH
|
William J Doherty
President, CS Division |
BUY
Exercise of conversion of derivative security
|
Direct | 80,000 Added 50.0% |
$2,664,000
$33.3 p/Share
|
Oct 29
2025 |
|
MRP
|
Matthew B. Gorson |
BUY
Open market or private purchase
|
Direct | 2,500 Added 12.1% |
$81,725
$32.69 p/Share
|
Oct 29
2025 |
|
UHT
|
Alan B Miller
President, and CEO |
BUY
Open market or private purchase
|
Direct | 12,247 Added 6.3% |
$453,383
$37.02 p/Share
|
Oct 29
2025 |
|
ECAT
|
Saba Capital Management, L.P.
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 75,953 Reduced 0.0% |
$1,257,022
$16.55 p/Share
|
Oct 29
2025 |
|
ASA
|
Saba Capital Management, L.P.
> 10% Shareholder |
BUY
Open market or private purchase
|
Indirect | 9,128 Added 0.0% |
$413,680
$45.32 p/Share
|
Oct 29
2025 |
|
WNC
|
Drew John Schwartzhoff
SVP, Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 744 Reduced 3.13% |
$6,182
$8.31 p/Share
|
Oct 29
2025 |
|
WNC
|
Donald Adrian Winston
SVP, Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct | 724 Reduced 1.57% |
$6,016
$8.31 p/Share
|
Oct 29
2025 |
|
CCFN
|
Brenda R H Williams
Director |
BUY
Open market or private purchase
|
Direct | 150 Added 8.0% |
$7,950
$53.0 p/Share
|
Oct 29
2025 |
|
EFSI
|
John D Stokely Jr |
SELL
Open market or private sale
|
Direct | 78 Reduced 0.58% |
$2,854
$36.6 p/Share
|
Oct 29
2025 |
|
EFSI
|
John D Stokely Jr |
SELL
Open market or private sale
|
Indirect | 5,815 Reduced 0.0% |
$212,829
$36.6 p/Share
|
Oct 29
2025 |
|
CSAI
|
Sheldon Richard Bentley
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 25,000 Reduced 14.29% |
$34,750
$1.39 p/Share
|
Oct 29
2025 |
|
INBK
|
David B Becker
Chairman and CEO |
BUY
Open market or private purchase
|
Direct | 5,000 Added 1.18% |
$93,350
$18.67 p/Share
|
Oct 29
2025 |
|
GD
|
Gregory S Gallopoulos
Senior VP, Gen. Counsel, Sec. |
SELL
Bona fide gift
|
Direct | 1,200 Reduced 0.94% |
-
|
Oct 29
2025 |
|
STLD
|
Miguel Alvarez
Senior Vice President |
SELL
Open market or private sale
|
Direct | 8,251 Reduced 6.58% |
$1,343,180
$162.79 p/Share
|
Oct 29
2025 |
|
SON
|
Paul Joachimczyk
CFO |
BUY
Open market or private purchase
|
Direct | 20,500 Added 50.0% |
$809,135
$39.47 p/Share
|
Oct 29
2025 |
|
TPL
|
Horizon Kinetics Asset Management LLC
> 10% Shareholder |
BUY
Open market or private purchase
|
Direct | 1 Added 0.0% |
$912
$912.12 p/Share
|
Oct 29
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Direct | 360 Added 0.29% |
$943
$2.62 p/Share
|
Oct 29
2025 |
|
RCG
|
Murray Stahl
President/Co-Portfolio Manager |
BUY
Open market or private purchase
|
Indirect | 774 Added 0.0% |
$2,027
$2.62 p/Share
|
Oct 29
2025 |
|
CCK
|
Caesar F Sweitzer
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 1.66% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CCK
|
Marsha C Williams
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 5.53% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CCK
|
Angela M Snyder
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 6.32% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CCK
|
B Craig Owens
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 3.62% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CCK
|
Stephen J Hagge
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 3.72% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CHMG
|
Jeffrey B Streeter
Director |
BUY
Open market or private purchase
|
Direct | 2,184 Added 6.26% |
$113,393
$51.92 p/Share
|
Oct 29
2025 |
|
CCK
|
Andrea J. Funk
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 2.37% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
CCK
|
Richard H Fearon
Director |
BUY
Grant, award, or other acquisition
|
Direct | 406 Added 3.36% |
$40,096
$98.76 p/Share
|
Oct 29
2025 |
|
RCUS
|
Juan C. Jaen
President |
SELL
Open market or private sale
|
Indirect | 77,840 Reduced 0.0% |
$1,661,884
$21.35 p/Share
|
Oct 29
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 464,169 Reduced 0.0% |
$64,162,080
$138.23 p/Share
|
Oct 29
2025 |
|
NTRA
|
Michael Burkes Brophy
CHIEF FINANCIAL OFFICER |
SELL
Open market or private sale
|
Direct | 1,867 Reduced 2.83% |
$355,383
$190.35 p/Share
|
Oct 29
2025 |
|
CRWV
|
Magnetar Financial LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 804,514 Reduced 0.0% |
$111,248,195
$138.28 p/Share
|
Oct 29
2025 |
|
MFH
|
Wilfred Zhong Kei Daye
CSO |
SELL
Open market or private sale
|
Direct | 1,800 Reduced 2.99% |
$20,664
$11.48 p/Share
|
Oct 29
2025 |
|
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct | 125 Added 50.0% |
$26,112
$208.9 p/Share
|
Oct 29
2025 |
|
ISRG
|
Myriam Curet
EVP & Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 125 Reduced 100.0% |
$67,875
$543.0 p/Share
|
Oct 29
2025 |
|
HOWL
|
Ansbert Gadicke |
SELL
Open market or private sale
|
Indirect | 134,240 Reduced 0.0% |
$208,072
$1.55 p/Share
|
Oct 29
2025 |
|
HOWL
|
Mpm Bio Ventures 2014, L.P. |
SELL
Open market or private sale
|
Indirect | 134,240 Reduced 0.0% |
$208,072
$1.55 p/Share
|
Oct 29
2025 |
|
HOWL
|
Luke Evnin |
SELL
Open market or private sale
|
Indirect | 86,154 Reduced 0.0% |
$133,538
$1.55 p/Share
|
Oct 29
2025 |
|
FIBK
|
Jonathan R Scott
> 10% Shareholder |
SELL
Open market or private sale
|
Indirect | 7,000 Reduced 0.0% |
$224,630
$32.09 p/Share
|
Oct 29
2025 |
|
INV
|
We Inn LLC |
SELL
Open market or private sale
|
Direct | 149,708 Reduced 1.82% |
$437,147
$2.92 p/Share
|
Oct 29
2025 |